通过受体载体蛋白4 (RTP4) 限制SARS-CoV-2的复制
Ramanjit Kaur1, Takuya Tada1, Nathaniel Roy Landau1
1Department of Microbiology, NYU Grossman School of Medicine , New York, New York, USA.
mBio
|June 29, 2023
概括
受体载体蛋白4 (RTP4) 通过结合病毒RNA,抑制病毒RNA合成来限制SARS-CoV-2的复制. 这种干扰素诱导蛋白对Omicron变种表现出活性,并为冠状病毒感染提供了潜在的治疗点.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 导致COVID-19大流行,需要发现新的抗病毒策略.
- 众所周知,干扰素诱导性宿主蛋白限制病毒复制,突出了它们作为抗病毒因素的潜力.
- 之前的研究表明,受体载体蛋白4 (RTP4) 限制了弗拉维病毒的复制.
研究的目的:
- 确定针对SARS-CoV-2的新型宿主限制因素.
- 描述受体载体蛋白4 (RTP4) 对冠状病毒的抗病毒活性.
- 研究RTP4在限制病毒复制中的作用机制.
主要方法:
- 用干扰素治疗的人类单细胞的RNA测序以识别诱导的基因.
- 检测候选基因,包括RTP4,对抗人类冠状病毒 (HCoV-OC43,SARS-CoV-2,Omicron变种) 的抗病毒活性.
- 分子和生化分析以确定RTP4的机制,包括RNA结合试验和病毒蛋白质合成评估.
主要成果:
- 受体载体蛋白4 (RTP4) 被确定为一种干扰素诱导基因.
- 人类RTP4有效地阻止了ACE2.CHME3细胞中HCoV-OC43,SARS-CoV-2和Omicron BA.1/BA.2变体的复制.
- RTP4通过其指直接与病毒基因组RNA结合,抑制了病毒RNA合成和随后的病毒蛋白质产生.
- 在感染SARS-CoV-2的小鼠中诱导了RTP4表达,尽管小鼠同类物对病毒不活跃.
结论:
- 受体载体蛋白4 (RTP4) 是对人类冠状病毒的强有力的宿主限制因素,包括SARS-CoV-2及其Omicron变体.
- RTP4通过直接结合病毒RNA而起作用,从而抑制病毒复制.
- RTP4代表了开发广谱抗冠状病毒药物的有前途的治疗标.
相关概念视频
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Viruses with RNA Genomes
58
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
58
Riboswitches
8.2K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.2K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K


